Metastases to the liver is the leading cause of death in patients with colorectal cancer.
Methods
The authors review the data on diagnosis and management of this clinical problem, and they discuss management options that can be considered.
Results
Complete surgical resection of metastases from colorectal cancer that are localized to the liver results in 5-year survival rates ranging from 26% to 40%.
Conclusions
By adding modalities such as targeted systemic therapy and other “local” treatments for liver metastases, further gains in survival are anticipated.
References
1.
JemalA., WardE., HaoY.Trends in the leading causes of death in the United States, 1970-2002. JAMA.2005; 294: 1255–1259.
2.
JemalA., MurrayT., WardE.Cancer statistics, 2005. CA Cancer J Clin.2005; 55: 10–30. Erratum in: CA Cancer J Clin. 2005; 55: 259.
3.
WilsonS.M., AdsonM.A.Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg.1976; 111: 330–334.
KemenyN., JarnaginW., GonenM.Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol.2003; 21: 3303–3309.
6.
BentremD.J., DematteoR.P., BlumgartL.H.Surgical therapy for metastatic disease to the liver. Annu Rev Med.2005; 56: 139–156.
7.
KeenW.W.Removal of an angioma of the liver by elastic constriction external to the abdominal cavity, with a table of 59 cases of operation for hepatic tumors. Pa Med J.1897; 1: 198.
8.
FosterJ.H.Survival after liver resection for secondary tumors. Am J Surg.1978; 135: 389–394.
9.
WagnerJ.S., AdsonM.A., Van HeerdenJ.A.The natural history of hepatic metastases from colorectal cancer: a comparison with resective treatment. Ann Surg.1984; 199: 502–508.
10.
AdsonM.A., van HeerdenJ.A., AdsonM.H.Resection of hepatic metastases from colorectal cancer. Arch Surg.1984; 119: 647–651.
11.
HughesK.S., SimonR., SonghorabodiS.Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery.1986; 100: 278–284.
12.
ScheeleJ., StanglR., Altendorf-HofmannA.Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg.1990; 77: 1241–1246.
13.
SchlagP., HohenbergerP., HerfarthC.Resection of liver metastases in colorectal cancer: competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol.1990; 16: 360–365.
14.
RosenC.B., NagorneyD.M., TaswellH.F.Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg.1992; 216: 493–505.
15.
GayowskiT.J., IwatsukiS., MadariagaJ.R.Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery.1994; 116: 703–711.
16.
ScheeleJ., StangR., Altendorf-HofmannA.Resection of colorectal liver metastases. World J Surg.1995; 19: 59–71.
17.
JamisonR.L., DonohueJ.H., NagorneyD.M.Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg.1997; 132: 505–511.
18.
FongY., FortnerJ., SunR.L.Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg.1999; 230: 309–321.
19.
ChotiM.A., SitzmannJ.V., TiburiM.F.Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg.2002; 235: 759–766.
20.
AbdallaE.K., VautheyJ.N., EllisL.M.Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg.2004; 239: 818–827.
21.
MutsaertsE.L., van RuthS., ZoetmulderF.A.Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: a 10-year single-institute experience. J Gastrointest Surg.2005; 9: 178–186.
22.
WoodingtonG.F., WaughJ.M.Results of resection of metastatic tumors of the liver. Am J Surg.1963; 105: 24–29.
23.
PestanaC., ReitemeierR.J.Moertel CG, et al. The natural history of carcinoma of the colon and rectum. Am J Surg.1964; 108: 826–829.
24.
CadyB., MonsonD.O., SwintonN.W.Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet.1970; 131: 697–700.
25.
LahrC.J., SoongS.J., CloudG.A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol.1983; 1: 720–726.
26.
AdsonM.A.Resection of liver metastases: when is it worthwhile?World J Surg.1987; 11: 511–520.
27.
WoodC.B., GillisC.R., BlumgartL.H.A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol.1976; 2: 285–288.
28.
StanglR., Altendorf-HofmannA., CharnleyR.M.Factors influencing the natural history of colorectal liver metastases. Lancet.1994; 343: 1405–1410.
29.
RougierP., MilanC., LazorthesF.Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Francaise de Cancerologie Digestive. Br J Surg.1995; 82: 1397–1400.
30.
ScheeleJ., Altendorf-HofmannA., GrubeT.Resection of colorectal liver metastases: what prognostic factors determine patient selection? [in German]Chirurg.2001; 72: 547–560.
31.
KatoT., YasuiK., HiraiT.Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum.2003; 46: S22–S31.
LeonardG.D., BrennerB., KemenyN.E.Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol.2005; 23: 2038–2048.
34.
JaffeB.M., DoneganW.L., WatsonF.Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet.1968; 127: 1–11.
35.
BengmarkS., HafstromL.The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer.1969; 23: 198–202.
36.
GoldbergR.M., SargentD.J., MortonR.F.A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol.2004; 22: 23–30. Epub 2003 Dec 9.
37.
TournigandC., AndreT., AchilleE.FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol.2004; 22: 229–237. Epub 2003 Dec 2.
38.
MoertelC.G., GundersonL.L., MailliardJ.A.Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group. J Clin Oncol.1994; 12: 21–27.
39.
WaneboH.J., SemoglouC., AttiyehF.Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg.1978; 135: 81–85.
40.
HeslinM.J., Medina-FrancoH., ParkerM.Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival. Arch Surg.2001; 136: 318–323. Erratum in: Arch Surg. 2001; 136: 809.
41.
Luna-PerezP., Rodriguez-CoriaD.F., ArroyoB.The natural history of liver metastases from colorectal cancer. Arch Med Res.1998; 29: 319–324.
42.
SuzukiS., SakaguchiT., YokoiY.Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery.2001; 129: 421–428.
43.
MuratoreA., PolastriR., BouzariH.Repeat hepatectomy for colorectal liver metastases: a worthwhile operation?J Surg Oncol.2001; 76: 127–132.
44.
TuttleT.M., CurleyS.A., RohM.S.Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases. Ann Surg Oncol.1997; 4: 125–130.
BozzettiF., BignamiP., MontaltoF.Repeated hepatic resection for recurrent metastases from colorectal cancer. Br J Surg.1992; 79: 146–148.
50.
HohenbergerP., SchlagP., SchwarzV.Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer. J Surg Oncol.1990; 44: 245–251.
51.
DeMatteoR.P., PaleseC., JarnaginW.R.Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg.2000; 4: 178–184.
52.
PetrowskyH., GonenM., JarnaginW.Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg.2002; 235: 863–871.
53.
AdamR., BismuthH., CastaingD.Repeat hepatectomy for colorectal liver metastases. Ann Surg.1997; 225: 51–62.
54.
YamamotoJ., KosugeT., ShimadaK.Repeat liver resection for recurrent colorectal liver metastases. Am J Surg.1999; 178: 275–281.
55.
HughesK.S., RosensteinR.B., SonghorabodiS.Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of long-term survivors. Dis Colon Rectum.1988; 31: 1–4.
56.
NordlingerB., PeschaudF., MalafosseR.Resection of liver metastases from colorectal cancer: how can we improve results?Colorectal Dis.2003; 5: 515–517.
57.
DociR., GennariL., BignamiP.Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg.1995; 82: 377–381.
58.
MatsumataT., TaketomiA., KawaharaN.Morbidity and mortality after hepatic resection in the modern era. Hepatogastroenterology.1995; 42: 456–460.
59.
2006 National Comprehensive Cancer Network. Available at: http://www.nccn.com. Accessed on December 29, 2005.
60.
RogersL.F.“My word, what is that?” Hounsfield and the triumph of clinical research. AJR Am J Roentgenol.2003; 180: 1501.
61.
LiL., WuP.H., MoY.X.CT arterial portography and CT hepatic arteriography in detection of micro liver cancer. World J Gastroenterol.1999; 5: 225–227.
62.
SchmidtJ., StrotzerM., FraunhoferS.Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: lesion-by-lesion analysis. World J Surg.2000; 24: 43–48.
63.
SahaniD.V., KalvaS.P.Imaging the liver. Oncologist.2004; 9: 385–397.
64.
ParkJ.H., NazarianL.N., HalpernE.J.Comparison of unenhanced and contrast-enhanced spiral CT for assessing interval change in patients with colorectal liver metastases. Acad Radiol.2001; 8: 698–704.
65.
OkanoK., YamamotoJ., OkabayashiT.CT imaging of intrabiliary growth of colorectal liver metastases: a comparison of pathological findings of resected specimens. Br J Radiol.2002; 75: 497–501.
66.
VallsC., AndiaE., SanchezA.Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. Radiology.2001; 218: 55–60.
67.
SainiS.Imaging of the hepatobiliary tract. N Engl J Med.1997; 336: 1889–1894.
68.
KamelI.R., BluemkeD.A.MR imaging of liver tumors. Radiol Clin North Am.2003; 41: 51–65.
69.
VoglT.J., SchwarzW., BlumeS.Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol.2003; 13: 262–272. Epub 2002 Sep 10.
70.
SemelkaR.C., CanceW.G., MarcosH.B.Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology.1999; 213: 86–91.
71.
YangM., MartinD.R., KarabulutN.Comparison of MR and PET imaging for the evaluation of liver metastases. J Magn Reson Imaging.2003; 17: 343–349.
72.
TruantS., HugloD., HebbarM.Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg.2005; 92: 362–369.
73.
JohnsonK., BakhshA., YoungD.Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer. Dis Colon Rectum.2001; 44: 354–357.
74.
FongY., SaldingerP.F., AkhurstT.Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg.1999; 178: 282–287.
75.
BoykinK.N., ZibariG.B., LilienD.L.The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Am Surg.1999; 65: 1183–1185.
76.
ZealleyI.A., SkehanS.J., RawlinsonJ.Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet. Radiographics.2001; 21: S55–S69.
77.
GrobmyerS.R., FongY., D'AngelicaM.Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases. Arch Surg.2004; 139: 1326–1330.
78.
CathelineJ.M., TurnerR., ChampaultG.Laparoscopic ultrasound of the liver. Eur J Ultrasound.2000; 12: 169–177.
79.
BismuthH., AdamR., LeviF.Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg.1996; 224: 509–520; discussion 520-522.
80.
EkbergH., TranbergK.G., AnderssonR.Determinants of survival in liver resection for colorectal secondaries. Br J Surg.1986; 73: 727–731.
81.
YamaguchiJ., YamamotoM., KomutaK.Hepatic resections for bilobar liver metastases from colorectal cancer. J Hepatobiliary Pancreat Surg.2000; 7: 404–409.
82.
HughesK., ScheeleJ., SugarbakerP.H.Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am.1989; 69: 339–359.
83.
NordlingerB., GuiguetM., VaillantJ.C.Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer.1996; 77: 1254–1262.
84.
WrayC.J., LowyA.M., MathewsJ.B.The significance and clinical factors associated with a subcentimeter resection of colorectal liver metastases. Ann Surg Oncol.2005; 12: 374–380. Epub 2005 Mar 29.
85.
EliasD., DebaereT., MuttilloI.Intraoperative use of radiofrequency treatment allows an increase in the rate of curative liver resection. J Surg Oncol.1998; 67: 190–191.
86.
WallaceJ.R., ChristiansK.K., PittH.A.Cryotherapy extends the indications for treatment of colorectal liver metastases. Surgery.1999; 126: 766–774.
87.
ParkinD.M., BrayF., FerlayJ.Global cancer statistics, 2002. CA Cancer J Clin.2005; 55: 74–108.
88.
BoyleP., FerlayJ.Cancer incidence and mortality in Europe, 2004. Ann Oncol.2005; 16: 481–488. Epub 2005 Feb 17.
89.
RuersT., BleichrodtR.P.Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer.2002; 38: 1023–1033.
90.
MartinR., PatyP., FongY.Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg.2003; 197: 233–242.
91.
VogtP., RaabR., RingeB.Resection of synchronous liver metastases from colorectal cancer. World J Surg.1991; 15: 62–67.
92.
ScheeleJ., StanglR., Altendorf-HofmannA.Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery.1991; 110: 13–29.
93.
JenkinsL.T., MillikanK.W., BinesS.D.Hepatic resection for metastatic colorectal cancer. Am Surg.1997; 63: 605–610.
JaeckD., BachellierP., WeberJ.C.Surgical treatment of synchronous hepatic metastases of colorectal cancers. Simultaneous or delayed resection [French]?Ann Chir.1996; 50: 507–16.
96.
BoltonJ.S., FuhrmanG.M.Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg.2000; 231: 743–751.
97.
FujitaS., AkasuT., MoriyaY.Resection of synchronous liver metastases from colorectal cancer. Jpn J Clin Oncol.2000; 30: 7–11.
98.
LyassS., ZamirG., MatotI.Combined colon and hepatic resection for synchronous colorectal liver metastases. J Surg Oncol.2001; 78: 17–21.
99.
MorrisD.L.Surgery for liver metastases: how many?ANZ J Surg.2002; 72: 2.
100.
AsbunH.J., TsaoJ.I., HughesK.S.Resection of hepatic metastases from colorectal carcinoma: the registry data. Cancer Treat Res.1994; 69: 33–41.
101.
LevitanN., HughesK.S.Management of non-resectable liver metastases from colorectal cancer. Oncology (Williston Park).1990; 4: 77–84, 89, 92.
102.
PostonG.J.Surgical strategies for colorectal liver metastases. Surg Oncol.2004; 13: 125–136.
103.
PostonG.J., AdamR., AlbertsS.OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol.2005; 23: 7125–7134.
104.
PrimroseJ.N.Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation. Gut.2002; 50: 1–5.
105.
BerneyT., MenthaG., MorelP.Total vascular exclusion of the liver for the resection of lesions in contact with the vena cava or the hepatic veins. Br J Surg.1998; 85: 485–488.
106.
KemenyN., HuangY., CohenA.M.Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med.1999; 341: 2039–2048.
107.
LorenzM., Staib-SeblerE., HochmuthK.Surgical resection of liver metastases of colorectal carcinoma: short and long-term results. Semin Oncol.2000; 27(5 Suppl 10): 112–119.
108.
GiacchettiS., ItzhakiM., GruiaG.Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol.1999; 10: 663–669.
109.
AdamR., AvisarE., AricheA.Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol.2001; 8: 347–353.
110.
WeinA., RiedelC., KockerlingF.Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid. Ann Oncol.2001; 12: 1721–1727.
111.
RivoireM., De CianF., MeeusP.Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma. Cancer.2002; 95: 2283–2292.
112.
AdamR., DelvartV., PascalG.Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg.2004; 240: 644–657.
113.
PozzoC., BassoM., CassanoA.Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol.2004; 15: 933–939.
114.
DelaunoitT., AlbertsS.R., SargentD.J.Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol.2005; 16: 425–429. Epub 2005 Jan 27.
115.
BirkmeyerJ.D., SiewersA.E., FinlaysonE.V.Hospital volume and surgical mortality in the United States. N Engl J Med.2002; 346: 1128–1137.
116.
FelibertiE.C., WagmanL.D.Radiofrequency ablation of liver metastases from colorectal cancer: where we are. Cancer Control.2006; 13: 48–51.
117.
PearsonA.S., IzzoF., FlemingR.Y.Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg.1999; 178: 592–599.
118.
WongS.L., EdwardsM.J., ChaoC.Radiofrequency ablation for unresectable hepatic tumors. Am J Surg.2001; 182: 552–557.
119.
MachiJ.Radiofrequency ablation for multiple hepatic metastases. Ann Surg Oncol.2001; 8: 379–380.
GruenbergerT., JourdanJ.L., ZhaoJ.Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases. Arch Surg.2001; 136: 1154–1157.
122.
SeifertJ.K., MorrisD.L.Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer. Br J Surg.1999; 86: 234–240.
123.
RuersT.J., JoostenJ., JagerG.J.Long-term results of treating hepatic colorectal metastases with cryosurgery. Br J Surg.2001; 88: 844–849.
124.
MetcalfeM.S., MullinE.J., MaddernG.J.Choice of surveillance after hepatectomy for colorectal metastases. Arch Surg.2004; 139: 749–754.
125.
MetcalfeM., MannC., MullinE.Detecting curable disease following hepatectomy for colorectal metastases. ANZ J Surg.2005; 75: 524–527.
126.
PfisterD.G., BensonAB3rd, SomerfieldM.R.Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. N Engl J Med.2004; 350: 2375–2382.
